Outset Medical, Inc. (OM)

Market Cap	222.66M
Revenue (ttm)	113.69M
Net Income (ttm)	-127.98M
Shares Out	17.70M
EPS (ttm)	-36.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,864
Open	11.98
Previous Close	12.11
Day's Range	11.63 - 12.58
52-Week Range	5.85 - 78.30
Beta	2.01
Analysts	Strong Buy
Price Target	60.00 (+376.95%)
Earnings Date	May 7, 2025

About OM

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and Tablo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 15, 2020
• Employees: 480
• Stock Exchange: NASDAQ
• Ticker Symbol: OM
• Website: https://www.outsetmedical.com

Financial Performance

In 2024, Outset Medical's revenue was $113.69 million, a decrease of -12.80% compared to the previous year's $130.38 million. Losses were -$127.98 million, -25.94% less than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for OM stock is "Strong Buy." The 12-month stock price forecast is $60.0, which is an increase of 376.95% from the latest price.

Price Target

$60.0

(376.95% upside)

Analyst Consensus: Strong Buy